GLP-1 Agonists and Hormonal Balance. Potential Effects on Menstrual Cycle Regularity. GLP-1 agonists have shown promising effects on menstrual cycle regularity, particularly in women with PCOS.
GLP-1 Receptor Agonist Therapy. At BFF Medical Wellness Clinic, we understand how challenging it can be to maintain a healthy weight and control blood sugar levels.
GLP-1 receptor agonists (exenatide, dulaglutide, liraglutide) remarkably protect against olanzapine-induced hyperglycemia. Enhancing endogenous GLP-1 levels (via DPP-4 inhibition) is also sufficient to dampen acute olanzapine-induced perturbations in glucose and lipid homeostasis. 6c.
However, GLP-1 drugs do not have extensive research on potential long-term side effects, and there are risks involved in taking this drug.
GLP-1 receptor activation. GLP-1 is an incretin hormone secreted by enteroendocrine L-cells and -cells in the pancreas and central nervous system. GLP-1 activates insulin secretion in response to elevated plasma glucose levels (13).
The GLP-1 receptor antagonist, exendin (9-39) (10 nmol, i.c.v.) did not modify blood glucose levels but it antagonized the glucose-lowering effect of exendin-4 (1 nmol, i.c.v.; P<0.05).
To determine the role of brain GLP-1 receptor (GLP-1R) on -cell function, we administered intracerebroventricular (i.c.v.) infusions of GLP-1 or the specific GLP-1 antagonist exendin-9 (Ex-9), in both an acute and a chronic setting.
